Ranibizumab for Age-Related Macular Degeneration

被引:0
|
作者
Trempe, Clement [1 ]
机构
[1] New England Eye Inst, Boston, MA USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 06期
关键词
DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:581 / 582
页数:2
相关论文
共 50 条
  • [41] Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
    Timothy Y. Y. Lai
    Wai-Man Chan
    David T. Liu
    Dennis S. Lam
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1877 - 1880
  • [42] Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration
    Bhatnagar, Pawan
    Spaide, Richard F.
    Takahashi, Beatriz S.
    Peragallo, Jason H.
    Freund, K. Bailey
    Klancnik, James M., Jr.
    Cooney, Michael J.
    Slakter, Jason S.
    Sorenson, John A.
    Yannuzzi, Lawrence A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 846 - 850
  • [43] Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
    Hurley S.F.
    Matthews J.P.
    Guymer R.H.
    Cost Effectiveness and Resource Allocation, 6 (1)
  • [44] Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
    Takeda, A. L.
    Colquitt, J.
    Clegg, A. J.
    Jones, J.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (09) : 1177 - 1182
  • [45] Assessment of the effectiveness and safety of ranibizumab in neovascular age-related macular degeneration
    Real Campana, Jose Manuel
    Carrera Lafuentes, Patricia
    Torron Fernandez-Blanco, Clemencia
    Huarte Lacunza, Rafael
    Varela Martinez, Isabel
    Rabanaque Hernandez, M. Jose
    MEDICINA CLINICA, 2011, 136 (11): : 471 - 477
  • [46] Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
    Karaca, Umut
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    Sobaci, Gungor
    Bayraktar, Mehmet Zeki
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 25 - 29
  • [47] PHARMACOECONOMIC EVALUATION OF RANIBIZUMAB IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN AUSTRIA
    Walter, E.
    Brennig, C.
    Moeremans, K.
    Thomas, V
    VALUE IN HEALTH, 2008, 11 (06) : A617 - A617
  • [48] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [49] Effect of Intravitreal Ranibizumab on Corneal Endothelium in Age-Related Macular Degeneration
    Perez-Rico, Consuelo
    Benitez-Herreros, Javier
    Castro-Rebollo, Maria
    Gomez-SanGil, Yanira
    Germain, Francisco
    Angeles Montes-Mollon, Maria
    Angel Teus, Miguel
    CORNEA, 2010, 29 (08) : 849 - 852
  • [50] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)